Oaktree Capital Management »

Bridgebio Pharma shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 2.4M 0.84
2024-03-31 $2.9M 3.5M 0.82
2023-12-31 $4.3M 5.0M 0.85
2023-09-30 $4.9M 6.5M 0.75
2023-06-30 $4.5M 7.3M 0.62
2023-03-31 $2.6M 4.0M 0.65

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
State Street Corp Etf Put Option (SPY)
Infinera Corp Common Stock (INFN)
Anglogold Ashanti Common Stock (AU)
Liberty Global Common Stock Call Option (LBTYA)
Star Bulk Carriers Corp Common Stock (SBLK)
Sunopta Common Stock (STKL)
Talen Energy Corp Common Stock (TLN)
Freeport-mcmoran Common Stock (FCX)
Runway Growth Finance Corp Common Stock (RWAY)
Vista Energy Sab De Cv Common Stock (VIST)
California Resources Corp Common Stock (CRC)

View all positions for Oaktree Capital Management

Top funds holding Bridgebio Pharma

Ing Investment Management
Braidwell
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
MacKay Shields
Nuveen Asset Management
Laurion Capital Management
Advent Capital Management
CNH Partners
State Street Corporation
Sona Asset Management
Wells Fargo & Company
Bank of America Corporation
Calamos Advisors

View all funds holding Bridgebio Pharma